Digital interventions, such as web-based programs, mobile apps, and text messaging, have been found to improve asthma control and medication adherence while reducing the use of "rescue" medications.
Findings were seen in youth reporting asthma diagnosis and secondhand exposure to e-cigarette aerosols.
A new quantitative personalized tool to predict asthma development in young children predicted asthma development reliably.
More than a fourth of teenagers with asthma reported depressive symptoms and greater symptom severity.
Researchers examined self-reported smoking habits at age 16 years among adolescents and parents in relation to phenotypes of asthma.
Children with asthma are prescribed antibiotics at a higher rate than children without asthma.
Pediatric pulmonologists most often chose symptom resolution following treatment with bronchodilators as the key clinical criterion for asthma diagnosis.
ProAir Digihaler is the first digital inhaler with built-in sensors that connects to a mobile application and provides data on inhaler use to patients with asthma and chronic obstructive pulmonary disease (COPD).
Children with asthma who had their fractional exhaled nitric oxide measured using a 6-second exhalation had consistent results that agreed with 10-second exhalation measurements.
The use of tralokinumab was not associated with oral corticosteroid-sparing effects in patients with severe asthma.
The study authors aimed to assess AE risk and complications of OCS use in patients with asthma since most studies only report them in non-asthmatic patients.
The trial analyzed the antibody response of 103 asthmatic patients to the seasonal influenza vaccine.
A 12% decrease in PM2.5 concentrations would result in an economic benefit of nearly $350 million annually.
The risk for asthma and wheezing in the first 10 years of childhood have been linked to a low maternal intake of vitamins D and E.
Omalizumab rescue therapy produced rapid results in a patient with refractory status asthmaticus.
A Mediterranean diet, including 2 servings of fatty fish per week, has the potential to reduce airway inflammation in children with asthma.
Mepolizumab demonstrated long-term safety and efficacy in the management of severe eosinophilic asthma.
Clinicians are gaining a better understanding of how asthma and allergies are regulated by the circadian clock, which will help patients better alleviate their symptoms.
In the absence of overweight and obesity, 10% of all pediatric asthma cases would be avoided.
Consistent associations were observed per 5 mm Hg higher maternal blood pressures in early pregnancy with lower FEV1/FVC.
Gaps in insurance coverage increased the odds of asthma-related emergency department intervention or hospitalization and exacerbations.
The Symptom Free Days Questionnaire may not be a reliable measurement in black patients with asthma.
Children of caregivers with poor asthma knowledge more likely to have prolonged hospital stay
The maximum symptom day has been confirmed as a reliable, responsive, and valid tool for measuring asthma symptom control.
Patients with both asthma and allergies had a significant increase in the number of prescriptions dispensed for controller medications.
Patients who received reslizumab experienced significantly greater improvements in each sleep-related related Asthma Quality of Life Questionnaire question score compared with placebo.
Significant improvements were seen in lung function in patients who received either dose of beclomethasone dipropionate.
The mean proportion of days covered in the fluticasone furoate/vilanterol group was significantly higher than in the budesonide/formoterol and fluticasone propionate/salmeterol groups.
By day 3, patients with severe eosinophilic asthma who received benralizumab required less use of rescue medication.
Add-on tiotropium therapy improved lung function compared with placebo in moderate asthma.